ALXO
ALX ONCOLOGY HOLDINGS INCCompany Information
- Company Name
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK0001810182
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ALXO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ALXO
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-02
- Last sale
- 2026-03-19
- Shares purchased (TTM)
- 3,330,876
- Shares sold (TTM)
- 24,240
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 93,099,363
- Shares outstanding
- 104,573,657
- Ownership
- 89.03%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -5.21%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 23 | 32 | 16 | 23 | 19 | 21 | 18 | 16 | 16 | 14 | 22 | 20 | ||||||
| Short Term Investments | 116 | 108 | 28 | 37 | 60 | 77 | 110 | 132 | 141 | 143 | 160 | 170 | ||||||
| Prepaid Expense And Other Assets Current | 5 | 5 | 6 | 6 | 6 | 5 | 7 | 7 | 12 | 10 | 6 | 9 | ||||||
| Assets Current | 143 | 146 | 51 | 67 | 85 | 103 | 134 | 156 | 169 | 168 | 189 | 199 | ||||||
| Property Plant And Equipment Net | 0 | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | ||||||
| Long Term Investments | 15 | 29 | 3 | 6 | 4 | 9 | 4 | 14 | 29 | 27 | 35 | 6 | ||||||
| Other Assets Noncurrent | 2 | 3 | 4 | 9 | 4 | 7 | 7 | 13 | 13 | 14 | 15 | 11 | ||||||
| Assets | 161 | 178 | 59 | 83 | 95 | 121 | 148 | 186 | 215 | 213 | 243 | 220 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 3 | 4 | 5 | 7 | 5 | 4 | 4 | 8 | 8 | 6 | 9 | 13 | ||||||
| Other Liabilities Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Long Term Debt Current | 0 | 5 | 5 | 4 | 3 | 2 | 0 | - | - | - | - | - | ||||||
| Accrued Liabilities And Other Liabilities | 12 | 11 | 14 | 17 | 11 | 13 | 13 | 24 | 30 | 26 | 27 | 22 | ||||||
| Liabilities Current | 15 | 20 | 25 | 28 | 19 | 19 | 19 | 32 | 38 | 32 | 36 | 35 | ||||||
| Long Term Debt Noncurrent | 10 | 3 | 5 | 6 | 7 | 8 | 9 | 10 | 10 | 10 | 10 | 10 | ||||||
| Other Liabilities Noncurrent | 0 | 4 | 4 | 4 | 5 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | ||||||
| Liabilities | 25 | 27 | 33 | 38 | 31 | 33 | 34 | 49 | 55 | 48 | 53 | 51 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 895 | 892 | 749 | 745 | 742 | 740 | 734 | 728 | 721 | 686 | 676 | 610 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 1 | -0 | 0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -759 | -741 | -723 | -700 | -678 | -652 | -621 | -592 | -561 | -522 | -486 | -441 | ||||||
| Stockholders Equity | 136 | 151 | 26 | 45 | 64 | 88 | 114 | 137 | 159 | 164 | 190 | 169 | ||||||
| Liabilities And Stockholders Equity | 161 | 178 | 59 | 83 | 95 | 121 | 148 | 186 | 215 | 213 | 243 | 220 | ||||||
| Common Stock Par Or Stated Value Per Share | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | ||||||
| Common Stock Shares Issued | 138 | 135 | 54 | 54 | 54 | 53 | 53 | 53 | 52 | 50 | 50 | 41 | ||||||
| Shares Outstanding | 138 | 135 | 54 | 54 | 54 | 53 | 53 | 53 | 52 | 50 | 50 | 41 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialALX ONCOLOGY HOLDINGS INC (ALXO) — SEC Financial Statements & Analysis
ALX ONCOLOGY HOLDINGS INC (ALXO) is a pharmaceutical preparations company, incorporated in DE. ALX ONCOLOGY HOLDINGS INC trades on Nasdaq as: ALXO. ALX ONCOLOGY HOLDINGS INC (ALXO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, ALX ONCOLOGY HOLDINGS INC carries a market cap of $280.77M, a P/E ratio of -3.47x, a P/B ratio of 2.06x, an enterprise value of $267.53M, and an EV/EBITDA multiple of -3.26x. On profitability, it posts a Return on Equity (ROE) of -80.65%, a Return on Assets (ROA) of -63.16%, and a Return on Invested Capital (ROIC) of -92.74%. Per share, it reports EPS of $-0.60, diluted EPS of $-0.60, free cash flow per share of $-0.52, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -30.61% year-over-year and EPS growth of -72.66% year-over-year. On the balance sheet, it maintains a current ratio of 9.71x, a quick ratio of 9.35x, working capital of $128.68M, a debt-to-equity ratio of 0.18x, a debt ratio of 0.15, an interest coverage ratio of -58.67x, free cash flow of $-70.95M (TTM), and net debt of $-13.25M. Figures sourced from SEC EDGAR.
- Market Cap
- $280.77M
- P/E TTM
- -3.47x
- EPS TTM
- $-0.60
- P/B TTM
- 2.06x
- ROE TTM
- -80.65%
- ROA TTM
- -63.16%
- Debt To Equity
- 0.18x
- Free Cash Flow TTM
- $-70.95M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ALX ONCOLOGY HOLDINGS INC in?
ALX ONCOLOGY HOLDINGS INC (ALXO) operates in the Pharmaceutical Preparations industry.
What exchange does ALXO trade on?
ALX ONCOLOGY HOLDINGS INC (ALXO) trades on the Nasdaq.
Where is ALX ONCOLOGY HOLDINGS INC incorporated?
ALX ONCOLOGY HOLDINGS INC is incorporated in DE.
When was ALX ONCOLOGY HOLDINGS INC (ALXO)'s most recent SEC filing?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is ALXO's market cap?
ALX ONCOLOGY HOLDINGS INC (ALXO) has a market capitalization of $280.77M as of 2026-06-30.
What is ALXO's EPS (earnings per share)?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s trailing twelve month EPS is $-0.60 as of 2026-06-30.
What is ALXO's ROE (return on equity)?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s trailing twelve month Return on Equity (ROE) is -80.65% as of 2026-06-30.
What is ALXO's ROA (return on assets)?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s trailing twelve month Return on Assets (ROA) is -63.16% as of 2026-06-30.
What is ALXO's ROIC (return on invested capital)?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s trailing twelve month Return on Invested Capital (ROIC) is -92.74% as of 2026-06-30.
What is ALXO's EV/EBITDA?
ALX ONCOLOGY HOLDINGS INC (ALXO)'s trailing twelve month EV/EBITDA is -3.26x as of 2026-06-30.